Life Science Access Academy Ltd invites you to their event
About this event
In this informative 60-minute masterclass for LSAA members, our panel of esteemed speakers and industry leaders will unravel the potential, challenges and innovative moves defining the landscape of 2024 and beyond for the sector.
As an election looms large, and with the prospect of more significant strategic and tactical change, we will help you identify the challenges and opportunities to enhance patient outcomes. It will also provide an opportunity to look at the new voluntary scheme for branded medicines pricing, access and growth (VPAG).
Join us for an immersive exploration of this dynamic landscape. Get the knowledge and insight you need to stay updated with the latest trends and best practices in generics, branded generics and biosimilars.
Hosted by
Mark has been the CEO of the British Generic Manufacturers Association (BGMA) since December 2020, representing the industry that supplies four out of five medicines to the NHS
Ian co-founded the Life Science Access Academy with Nigel Robbins to bring together all the best ideas in people development from more than 20 innovative specialist consultancies.
Kristine Oberte has been in the pharmaceutical industry for more than a decade. She has an educational background in organic chemistry and an MBA, different experiences in administration, research and training, sales & marketing and management areas.
Results-driven director, with pharmaceutical and medical device expertise in EMEA, US, LatAm and Asia Pacific.
Peter Ballard, based in Dorchester, GB, is currently a UK Head at Xiromed, LLC, bringing experience from previous roles at the British Generic Manufacturers Association (BGMA), Accord Healthcare and Dexcel Pharma. Peter Ballard holds a 1986 – 1991 Bachelor Of Science in Zoology, Physiology @ Royal Holloway, University of London.
Clara has worked at Accord Healthcare for over 15 years. She has held several senior commercial roles across regional sales, national accounts and, most recently, as the director responsible for Accord UK’s generics commercial, sales and marketing teams.
LSAA is a truly Global Membership Community for all staff from across the Life Science sector including: commercial, clinical and financial sales teams, medics and support teams.
